Reduced frequency and severity of infusion-related adverse events after change in ofatumumab infusion regimen: comment on the article by Østergaard et al.

Source:http://linkedlifedata.com/resource/pubmed/id/20967857

Download in:

View as

General Info

PMID
20967857